These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 26919414)

  • 21. Perioperative adverse events attributed to α2-adrenoceptor agonists in patients not at risk of cardiovascular events: systematic review and meta-analysis.
    Demiri M; Antunes T; Fletcher D; Martinez V
    Br J Anaesth; 2019 Dec; 123(6):795-807. PubMed ID: 31623842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atenolol as a comparator in outcome trials in hypertension: a correct choice in the past, but not for the future?
    Dahlöf B; Devereux RB; Kjeldsen SE; Lyle PA; Zhang Z; Edelman JM
    Blood Press; 2007; 16(1):6-12. PubMed ID: 17453746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy.
    Khan NA; McAlister FA; Lewanczuk RZ; Touyz RM; Padwal R; Rabkin SW; Leiter LA; Lebel M; Herbert C; Schiffrin EL; Herman RJ; Hamet P; Fodor G; Carruthers G; Culleton B; DeChamplain J; Pylypchuk G; Logan AG; Gledhill N; Petrella R; Campbell NR; Arnold M; Moe G; Hill MD; Jones C; Larochelle P; Ogilvie RI; Tobe S; Houlden R; Burgess E; Feldman RD;
    Can J Cardiol; 2005 Jun; 21(8):657-72. PubMed ID: 16003449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vasodilators in hypertension--a review with special emphasis on the combined use of vasodilators and beta-adrenoceptor blockers.
    Eggertsen R; Hansson L
    Int J Clin Pharmacol Ther Toxicol; 1985 Aug; 23(8):411-23. PubMed ID: 2864319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Should beta-blockers be used in the treatment of cocaine-associated acute coronary syndrome?
    Page RL; Utz KJ; Wolfel EE
    Ann Pharmacother; 2007 Dec; 41(12):2008-13. PubMed ID: 17956961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular effects of cocaine in humans: laboratory studies.
    Foltin RW; Fischman MW; Levin FR
    Drug Alcohol Depend; 1995 Mar; 37(3):193-210. PubMed ID: 7796714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cocaine-induced myocardial ischemia and infarction: pathophysiology, recognition, and management.
    Pitts WR; Lange RA; Cigarroa JE; Hillis LD
    Prog Cardiovasc Dis; 1997; 40(1):65-76. PubMed ID: 9247556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment advances for cocaine-induced ischemic stroke: focus on dihydropyridine-class calcium channel antagonists.
    Johnson BA; Devous MD; Ruiz P; Ait-Daoud N
    Am J Psychiatry; 2001 Aug; 158(8):1191-8. PubMed ID: 11481148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of increased heart rate on clinical outcomes in hypertension: implications for antihypertensive drug therapy.
    Palatini P; Benetos A; Julius S
    Drugs; 2006; 66(2):133-44. PubMed ID: 16451089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual cocaine and methamphetamine cardiovascular toxicity: rapid resolution with labetalol.
    Richards JR; Lange RA; Arnold TC; Horowitz BZ
    Am J Emerg Med; 2017 Mar; 35(3):519.e1-519.e4. PubMed ID: 27707569
    [No Abstract]   [Full Text] [Related]  

  • 32. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis.
    Psaty BM; Smith NL; Siscovick DS; Koepsell TD; Weiss NS; Heckbert SR; Lemaitre RN; Wagner EH; Furberg CD
    JAMA; 1997 Mar; 277(9):739-45. PubMed ID: 9042847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
    Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
    JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Controlled hypotension: a guide to drug choice.
    Degoute CS
    Drugs; 2007; 67(7):1053-76. PubMed ID: 17488147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recognition and management of pulmonary hypertension.
    Wanstall JC; Jeffery TK
    Drugs; 1998 Dec; 56(6):989-1007. PubMed ID: 9878988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.
    Ettehad D; Emdin CA; Kiran A; Anderson SG; Callender T; Emberson J; Chalmers J; Rodgers A; Rahimi K
    Lancet; 2016 Mar; 387(10022):957-967. PubMed ID: 26724178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Controlled hypotension in children: a critical review of available agents.
    Tobias JD
    Paediatr Drugs; 2002; 4(7):439-53. PubMed ID: 12083972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clevidipine for the treatment of severe hypertension in adults.
    Nguyen HM; Ma K; Pham DQ
    Clin Ther; 2010 Jan; 32(1):11-23. PubMed ID: 20171407
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.